Clinical Trial

Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents

Study acronym: GenV
Recruiting
View on ClinicalTrials.gov →
Summary
Generation Victoria (GenV) is a longitudinal, population-based study of Victorian children and their parents that will bring together data on a wide range of conditions ,exposures and outcomes. GenV blends study-collected, study-enhanced and linked data. It will be multi-purpose, supporting observational, interventional, health services and policy research within the same cohort. It is designed to address physical, mental and social issues experienced during childhood, as well as the antecedents of a wide range of diseases of ageing. It seeks to generate translatable evidence (prediction, prevention, treatments, services) to improve future wellbeing and reduce the future disease burden of children and adults. The GenV Cohort 2020s is open to all children born over a two-year period, and their parents, residing in the state of Victoria Australia. The GenV Cohort 2020s is preceded by an Advance Cohort of children born between 5 Dec 2020 and 3 October 2021, and their parents. This comprises all families recruited at GenV's Vanguard hospital (Joan Kirner Women's and Children's) and at birthing hospitals throughout Victoria as GenV scaled up to commence recruiting for the GenV Cohort 2020s. The Advance Cohort have ongoing and full participation in GenV for their lifetime unless they withdraw but may have less complete data and biosamples.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-05-23; most recent amendment 2025-07-30.
Trial Details
NCT Number NCT05394363
Lead Sponsor Murdoch Childrens Research Institute
Collaborators: The Paul Ramsay Foundation, Royal Children's Hospital, Victoria State Government, Royal Children's Hospital Foundation, University of Melbourne, National Health and Medical Research Council, Australia, Medical Research Future Fund, Angliss Health Service, Bairnsdale Regional Health Service, Grampians Health - Ballarat Base Hospital, Bass Coast Regional Health, The Bays Private Hospital, Benalla & District Memorial Hospital, Bendigo Hospital, Box Hill Hospital, Cabrini Private Hospital, Casey Hospital, Castlemaine Hospital, Central Gippsland Health Service, Colac Area Health, Dandenong Hospital, Bacchus Marsh - Western Health (formerly Djerriwarrh Health Service), East Grampians Health Service, Echuca Regional Health, Epworth Freemason's Private Hospital, Frances Perry Private Hospital, Peninsula Health, Epworth Geelong, Geelong University Hospital, Goulburn Valley Health, Hamilton Base Hospital, Jessie McPherson Private Hospital, Joan Kirner Women's and Children's Hospital, The Kilmore & District Hospital, Latrobe Regional Hospital, Leongatha Memorial Hospital, Mansfield District Hospital, Maryborough District Health Service, Mercy Hospital for Women, Mercy Werribee Public Hospital, Mildura Base Hospital, Mitcham Private Hospital, Monash Medical Centre, Northeast Health Wangaratta, The Northern Hospital, Northpark Private Hospital, Peninsula Private Hospital, Royal Women's Hospital, Sandringham & District Memorial Hospital, South Gippsland Hospital, South West Healthcare Camperdown, South West Healthcare Warnambool, St John of God Hospital Ballarat, St John of God Hospital Bendigo, St John of God Hospital Berwick, St John of God Hospital Geelong, St Vincents Private Hospital, Swan Hill District Hospital, Waverley Private Hospital, West Gippsland Healthcare Group, Grampians Health - Horsham (formerly Wimmera Health Care Group), Albury Wodonga Health, Yarrawonga District Health Service, Portland District Health
Conditions Mental Health, Child Wellbeing, Infant Health, Child Health, Reproductive Health, Healthy Aging, Health Equity, Quality of Life +17 more
Enrollment 150,000 participants
Start Date 2021-10-04
Primary Completion 2033-10 (estimated)
Study Completion 2033-10 (estimated)
Updated on ClinicalTrials.gov 2025-08-03